Harpoon Therapeutics Inc (DELISTED) (HARP:DL)
23.01
0.00 (0.00%)
USD |
NASDAQ |
Mar 11, 16:00
Harpoon Therapeutics 1 Year Total Returns (Daily)
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
March 11, 2024 | 248.6% |
March 08, 2024 | 217.4% |
March 07, 2024 | 205.1% |
March 06, 2024 | 209.2% |
March 05, 2024 | 194.1% |
March 04, 2024 | 193.9% |
March 01, 2024 | 205.9% |
February 29, 2024 | 196.2% |
February 28, 2024 | 196.4% |
February 27, 2024 | 198.0% |
February 26, 2024 | 209.9% |
February 23, 2024 | 205.7% |
February 22, 2024 | 187.0% |
February 21, 2024 | 171.7% |
February 20, 2024 | 162.8% |
February 16, 2024 | 166.9% |
February 15, 2024 | 176.9% |
February 14, 2024 | 129.1% |
February 13, 2024 | 93.71% |
February 12, 2024 | 101.3% |
February 09, 2024 | 104.1% |
February 08, 2024 | 106.9% |
February 07, 2024 | 62.99% |
February 06, 2024 | 97.79% |
February 05, 2024 | 119.1% |
Date | Value |
---|---|
February 02, 2024 | 118.9% |
February 01, 2024 | 102.8% |
January 31, 2024 | 106.8% |
January 30, 2024 | 117.2% |
January 29, 2024 | 89.83% |
January 26, 2024 | 138.3% |
January 25, 2024 | 143.5% |
January 24, 2024 | 151.6% |
January 23, 2024 | 146.2% |
January 22, 2024 | 158.8% |
January 19, 2024 | 161.7% |
January 18, 2024 | 161.6% |
January 17, 2024 | 131.4% |
January 16, 2024 | 169.5% |
January 12, 2024 | 176.5% |
January 11, 2024 | 184.5% |
January 10, 2024 | 180.6% |
January 09, 2024 | 198.1% |
January 08, 2024 | 198.1% |
January 05, 2024 | 31.88% |
January 04, 2024 | 46.93% |
January 03, 2024 | 48.31% |
January 02, 2024 | 51.58% |
December 29, 2023 | 64.81% |
December 28, 2023 | 91.62% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-92.09%
Minimum
Dec 28 2022
248.6%
Maximum
Mar 11 2024
-24.12%
Average
-49.70%
Median
1 Year Total Returns (Daily) Benchmarks
Merck & Co Inc | -1.33% |
Axonics Inc | 34.06% |
Johnson & Johnson | 7.09% |
Boston Scientific Corp | 65.28% |
Ambrx Biopharma Inc (DELISTED) | -- |